Your browser doesn't support javascript.
loading
Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies.
Berghoff, A S; Sessa, C; Yang, J C-H; Tsourti, Z; Tsang, J; Tabernero, J; Peters, S; Linardou, H; Letsch, A; Haanen, J; Garralda, E; Garassino, M C; Furness, A J S; Felip, E; Dimopoulou, G; Dafni, U; Choo, S P; Banerjee, S; Bajpai, J; Adjei, A A; Garrido, P.
Afiliación
  • Berghoff AS; Division of Oncology, Department of Medicine 1, Medical University of Vienna, Bern, Switzerland. Electronic address: Anna.Berghoff@meduniwien.ac.at.
  • Sessa C; Ente Ospedaliero Cantonale, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Yang JC; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Tsourti Z; Frontier Science Foundation-Hellas, Athens, Greece.
  • Tsang J; Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
  • Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), UVic-UCC, Barcelona, Spain.
  • Peters S; Oncology Department - CHUV, Lausanne University, Lausanne, Switzerland.
  • Linardou H; 4th Oncology Department, Metropolitan Hospital, Athens, Greece.
  • Letsch A; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Haanen J; Division of Medical Oncology, The Netherlands Cancer Institute (NKI), Amsterdam, Netherlands.
  • Garralda E; Early Drug Development Unit, VHIO - Vall d'Hebron Institute of Oncology, HUVH - Vall d'Hebron University Hospital, Barcelona, Spain.
  • Garassino MC; University of Chicago Medicine & Biological Sciences, Section of Hematology | Oncology, Chicago, USA.
  • Furness AJS; Royal Marsden NHS Foundation Trust, London, UK.
  • Felip E; Medical Oncology Department, Vall d'Hebron University Hospital, Thoracic Oncology and H&N Cancer Unit, Vall d'Hebron Institute of Oncology (VHIO), UVic-UCC, Barcelona, Spain.
  • Dimopoulou G; Frontier Science Foundation-Hellas, Athens, Greece.
  • Dafni U; Laboratory of Biostatistics, School of Heath Sciences, National and Kapodistrian University of Athens and Frontier Science Foundation-Hellas, Athens, Greece.
  • Choo SP; Curie Oncology Singapore, National Cancer Centre Singapore, Singapore.
  • Banerjee S; The Royal Marsden NHS Foundation Trust, Institute of Cancer Research, London, UK.
  • Bajpai J; Tata Memorial Centre, Homi-bhabha National Institute, Mumbai, India.
  • Adjei AA; Mayo Clinic, Rochester, USA.
  • Garrido P; Universidad de Alcalá, Medical Oncology Department, IRYCIS, Hospital Universitario Ramón y Cajal, Madrid, Spain.
ESMO Open ; 6(6): 100281, 2021 12.
Article en En | MEDLINE | ID: mdl-34924143
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oncólogos / Liderazgo Límite: Female / Humans / Male Idioma: En Revista: ESMO Open Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oncólogos / Liderazgo Límite: Female / Humans / Male Idioma: En Revista: ESMO Open Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido